Terms: = Sarcomas AND SMAD3, JV15-2, 4088, ENSG00000166949, P84022, Smad3, MADH3, HsT17436, Smad 3, DKFZp686J10186, HSPC193, DKFZP586N0721, MGC60396 AND Diagnosis
5 results:
1. Recent advances in the diagnosis, classification and molecular pathogenesis of cutaneous mesenchymal neoplasms.
Papke DJ; Hornick JL
Histopathology; 2022 Jan; 80(1):216-232. PubMed ID: 34958499
[TBL] [Abstract] [Full Text] [Related]
2. Update on Cutaneous Soft Tissue Tumors.
Dermawan JK; Ko JS; Billings SD
Surg Pathol Clin; 2021 Jun; 14(2):195-207. PubMed ID: 34023100
[TBL] [Abstract] [Full Text] [Related]
3. EWSR1-smad3 fibroblastic tumour of bone: expanding the clinical spectrum.
De Noon S; Flanagan AM; Tirabosco R; O'Donnell P; Amary F
Skeletal Radiol; 2021 Feb; 50(2):445-450. PubMed ID: 32710151
[TBL] [Abstract] [Full Text] [Related]
4. Anticancer activity of halofuginone in a preclinical model of osteosarcoma: inhibition of tumor growth and lung metastases.
Lamora A; Mullard M; Amiaud J; Brion R; Heymann D; Redini F; Verrecchia F
Oncotarget; 2015 Jun; 6(16):14413-27. PubMed ID: 26015407
[TBL] [Abstract] [Full Text] [Related]
5. Overexpression of smad7 blocks primary tumor growth and lung metastasis development in osteosarcoma.
Lamora A; Talbot J; Bougras G; Amiaud J; Leduc M; Chesneau J; Taurelle J; Stresing V; Le Deley MC; Heymann MF; Heymann D; Redini F; Verrecchia F
Clin Cancer Res; 2014 Oct; 20(19):5097-112. PubMed ID: 25107916
[TBL] [Abstract] [Full Text] [Related]
